Dr. Reddys Labs (RDY) Reports Q4 EPS of $0.07
Tweet
Share
E-mailGet Alerts RDY Hot Sheet
Join SI Premium – FREE
Dr. Reddys Labs (NYSE: RDY) reported Q4 EPS of $0.07, versus $0.46 reported last year. Revenue for the quarter came in at $567 billion, versus $584 billion reported last year.
For earnings history and earnings-related data on Dr. Reddys Labs (RDY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
- Principal Financial Group to acquire Beam Benefits, a small-business insurer
- TaiMed Biologics gets TFDA drug license notice for HIV therapy Trogarzo
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
